|
I. INTRODUCTION
Aims and Objectives of the Program:
A graduate program in Experimental Pathology leading to the
Ph.D. degree is offered within the School of Biological Sciences
and the School of Medicine. Therefore, the degree title is Doctor
of Philosophy in the Biological Sciences with a Concentration
in Experimental Pathology. The program recruits students
through the combined graduate training program in Molecular
Biology, Genetics, and Biochemistry (MBGB). The MBGB program
administers the first year curriculum. The application for
this program can be found online. For questions about the application
process, refer to the MBGB page
under Prospective Students. Experimental Pathology
is the study of disease, most notably human diseases and disease
processes. While it is true that many programs at the University
of California in Irvine have elements of their training program
that pertain to human disease and disease processes, no single
program makes the study of human disease the central tenet
of its degree program.
Experimental pathology is an increasingly critical area of
scientific research. While the National Institutes of Health
has always maintained the importance of human health in its
granting process, new technologies have made the study of human
diseases ever more central to scientific discovery. Indeed,
newer experimental approaches (e.g., transgenic mouse technologies)
and knowledge bases such as the human, mouse and rat genomes,
make studies on the molecular basis of human disease an exploding
area of research interest and importance.
The graduate program in Experimental Pathology will feed new
scientists into this ever-expanding area of human disease research.
The aim of the program is to provide graduate students with
the training necessary to become lead scientists studying the
molecular bases of human diseases. Providing students with
extensive training in molecular and cell biology, genetics,
and biochemistry will prepare trainees for further concentration
in Experimental Pathology. Therefore, this program is
a member of the combined graduate training program in MBGB.
In the first year, students are required to take the MBGB
curriculum,
existing of courses in proteins, nucleic acids, cell biology,
and genetics. Students interested in Experimental Pathology
will likely join the Experimental
Pathology track within MBGB during the first year. With
this strong foundation, students in the program will join the
Pathology & Laboratory Medicine department in the spring or summer quarter of their
first year. At this time, extensive study in human disease
related research will begin in the laboratories of program
faculty. Students will then have the opportunity to pursue
further specialization of their training in areas including,
but not limited to, neuropathology (mechanisms of neurologic
disease), oncogenesis (mechanisms of human cancer), immunopathology
(immunologic mechanisms of disease), molecular pathology (genetic
basis of human disease), and infectious disease (molecular
mechanisms of disease caused by viral, bacterial, fungal, and
parasitic agents). The subsequent course work of students
includes at least one didactic course per academic year concentrated
in their area of research interest. These courses are outlined
in greater detail below.
The objectives of this program are:
- To provide students with the molecular and genetic
knowledge necessary to understand the molecular bases of
human diseases and to genetically manipulate organisms and/or
cells to study these mechanisms.
- To provide graduate students with sufficient understanding
of known human disease processes to enable them to ask pertinent
experimental questions to answer new and novel questions
related to human disease and disease processes.
- To provide the scientists of tomorrow, both academic
and industry, with the knowledge necessary to address the
important genetic and molecular causes of the most important
diseases afflicting humans.
These objectives are unique among the programs within MBGB
and within the University of California, Irvine.
II. THE PROGRAM.
1. Undergraduate Preparation for Admission.
Admission to the program is through the combined program
in Molecular Biology, Genetics, and Biochemistry. Therefore,
students are admitted by and into the MBGB program, rather
than directly into this degree program concentration. As defined
by MBGB:
Applicants must have completed by the time of matriculation
a baccalaureate degree. The GRE General Test is required.
Applicants should have basic training in biology, physics, and chemistry. The ideal preparation includes introductory as well as some advanced courses in biology (cell biology, developmental biology, genetics, molecular biology), biochemistry, organic chemistry, physical chemistry, calculus, statistics, and physics. Demonstrated experience in laboratory research is very strongly advised.
Admission decisions are made on the basis of an overall evaluation of an applicant's preparation and potential to complete a rigorous program of advanced study in biology. Particular attention is paid to the applicant's academic experience, motivation and potential for research. The latter should be documented by reference letters from individuals in positions to judge research potential. Evaluations are based on the applicant's academic record. Graduate Record Examination scores, prior laboratory research experience, letters of recommendation, a personal statement, and a personal interview.
2. Foreign Language Requirement.
The MBGB program has no foreign language requirement nor
does the Ph.D. Program in Biological Sciences.
3. Program of Study.
- Specific Fields of Emphasis-Biological Sciences
with a concentration in Experimental Pathology.
- Plan: Doctor of Philosophy degree.
- Unit Requirements: All students must take at least
one didactic course per academic year after year 1. Students
must take additional units to be enrolled on a full-time
status throughout their graduate training.
- Required and recommended courses: Students will
be enrolled in the combined graduate program in Molecular
Biology, Genetics, and Biochemistry during the first year
of the program.
Core requirements-year 1: During the first year, students are required
to take four core courses that cover fundamental concepts in molecular and cell biology, genetics and biochemistry, as follows:
Fall Quarter: Protein Structure and Function (Mol Bio 204)
Winter Quarter: Structure and Biosynthesis of Nucleic Acids (Mol Bio 203)
AND: Cell Biology (Dev Bio 231B)
OR Molecular, Cellular, & Developmental
Neurobiology (Dev Bio 231D).
AND: T.A. Training Workshop (Dev Bio 202B)
OR: Cell Biology (Dev Bio 231B)
OR: Molecular, Cellular & Developmental Neurobiology (Dev Bio 231D)
OR: System Cell Biology (Dev Bio 232)
Spring Quarter: Regulation of Gene Expression (Mol Bio 206)
AND: Responsible Conduct of Research (MMG 250)
OR: Molecular Genetics (Mol Bio 207)
OR: Developmental Genetics (Dev Bio 210)
Graduate students may take elective courses relevant to their area of specialization. Certain tracks may have specific recommendations for elective courses.
Students are also required to do two laboratory
rotations in two different laboratories during the first year.
The requirement for two different laboratory rotations may
be waived for students in the Medical Scientist Training Program.
Students are encouraged to do at least three rotations in laboratories
that provide exposure to diverse research topics and a wide
variety of experimental approaches. Such varied research opportunities
provide a rewarding academic experience. Students select a
thesis mentor and laboratory at the completion of the Spring
Quarter in the first year and begin work to complete a Ph.D.
thesis based upon their own original laboratory research.
In addition, students who choose to join the program leading
to a Ph.D. in Biological Sciences with a concentration in Experimental
Pathology are required to take the following course in Experimental
Pathology: Path 225: Molecular Mechanisms of Human Disease.
This course is offered every Spring Quarter of odd years. This course may be taken at any time during the course
of the students training but should be completed
in the first two or three years of the program.
Core-elective courses: From the following list, and
any other core-elective courses suggested by participating
faculty and approved by the graduate advisor, each student
will take at least one core-elective in the first year and
complete a total of two core-electives by the end of the second
year. Students are required to take a minimum of one didactic
core-elective course for five years of graduate training. In
the case of completion of all graduate requirements prior to
five years, no additional coursework will be required. After
five years, no additional didactic course work is required.
Path 230-236 are courses derived from the medical school
pathology course.
Biochem 212: Signal Transduction and Growth
Control
Dev Bio 231B: Molecular, Cellular & Developmental Neurobiology (if
not taken year 1)
Mol Bio 217A: Cancer Biology I
Mol Bio 217B: Cancer Biology II
Mol Bio 218: Clinical Cancer for Basic Scientists
M&MG 215: Molecular Immunology
M&MG 222: Molecular Pathogenesis of Viral Infections
Path 221/M&MG 221: Immunopathogenic Mechanisms of Disease
Path 225/M&MG 225: Molecular Mechanisms of Human Disease
Path 230: Principles of Experimental Pathology
Path 231: Pathology of Cardiovascular Diseases
Path 232: Pathology of Pulmonary Diseases
Path 233: Pathology of Renal Diseases
Path 234: Pathology of Gastrointestinal Diseases
Path 235: Pathology of Genitourinary Diseases
Path 236: Graduate Neuropathology
Path 271AB: Molecular Physiology & Disease
Throughout the training program, students who are doing their thesis research under the Experimental Pathology
concentration are required to enroll in Path 200 for research
credit, under their research advisor, and Path 203, a literature
review course. Students are also required to participate in the Pathology
& Laboratory Medicine department research seminar series, Path 204, which has research in progress
presentations from faculty, postdoctoral fellows, and graduate
students. This seminar series currently meets twice monthly.
As the graduate program grows, the seminar series will become
more frequent.
Teaching Component: Per the MBGB Program-all students
in the MBGB program are required to teach during their first
and second years of study. Students enroll in Mol Bio 399 (University
Teaching) and teach in either undergraduate lecture or undergraduate
laboratory courses within either the Departments of Developmental
and Cell Biology or Molecular Biology and Biochemistry. In
general, students are teaching assistants in a total of three
courses. Previously, teaching assistant activity has been entirely
in year two of the students graduate program. More recently,
students begin by teaching in the Spring Quarter of their first
year and, additionally, in the Fall and Winter Quarters of
their second year. This is arranged by MBGB in coordination
with the respective departments. All students in Experimental
Pathology are subject to the same teaching requirements
as other MBGB students.
4. Preliminary Examination.
At the end of the first year, students must demonstrate proficiency by passing a preliminary qualifying exam. The purpose of this exam is to verify that you have completed the goals of the MBGB first-year program. These are:
- to establish a foundation of knowledge in the relevant disciplines
- to acquire an understanding of research methods including the responsible conduct of research
- to sharpen your critical thinking abilities so that you are ready to begin thesis research in which you will take major responsibility for the design, conduct and publication of Ph.D. - level research projects
The possible outcomes of the exam are:
- Pass.
- Fail with an opportunity to retake the exam within one month (same committee). Possible outcomes are 1 and 3 on this list.
- Fail.
The committee decision is referred to the Program Director for action. Students who pass the exam will normally move immediately to departmental Ph.D. Programs.
5. Thesis and Dissertation.
During the second year of the program, students will begin
thesis research in the laboratory of faculty within Experimental
Pathology. Once sufficient research progress has occurred,
usually within the second year in Experimental Pathology (third
year in the graduate program), the student will Advance to
Candidacy. The student will prepare a twenty-five page (double-spaced) written
proposal for dissertation research and orally defend this proposal
before the Advancement to Candidacy Committee. This committee
will consist of five faculty members, one of whom must not hold an appointment in the Department of Pathology & Laboratory Medicine
and at least three, including the thesis mentor, must hold appointments
in the Department of Pathology & Laboratory Medicine. After successful Advancement
to Candidacy, a Doctoral Committee will be formed, selected
from the Advancement to Candidacy committee. The composition
of this committee will be at least three members, a majority
of which must be from the Department of Pathology & Laboratory Medicine. All five
members of the Advancement to Candidacy committee can be selected
for the dissertation committee. The purpose of the committee
is to guide the students progress towards completion
of the dissertation. When the students thesis advisor
and the remaining members of the Doctoral Committee determine
that a sufficient body of original research has been completed,
the student will prepare the thesis for a public defense before
the Doctoral Committee.
6. Final Examination.
The students oral defense of the dissertation before
the doctoral committee constitutes the final examination.
7. Sample Program.
Due to the number of electives and the diverse nature of Experimental
Pathology training, no set program will exist. For example,
some students may choose a heavy emphasis on neuropathology,
with elective courses in neuroanatomy, neurological development,
and neuropathology. Other students may specialize in the pathogenesis
of cancer with a heavy emphasis on genetics, cell signaling,
and cell and cancer biology. Nevertheless, a general program
overview can be offered as demonstrated below.
Year 1 (As determined by the MBGB Program):
Fall Quarter: Protein Structure and Function (Mol Bio 204)
Winter Quarter: Structure and Biosynthesis of Nucleic Acids (Mol Bio 203)
AND: Cell Biology (Dev Bio 231B)
OR Molecular, Cellular, & Developmental
Neurobiology (Dev Bio 231D).
AND: T.A. Training Workshop (Dev Bio 202B)
OR: Cell Biology (Dev Bio 231B)
OR: Molecular, Cellular & Developmental Neurobiology (Dev Bio 231D)
OR: System Cell Biology (Dev Bio 232)
Spring Quarter: Regulation of Gene Expression (Mol Bio 206)
AND: Responsible Conduct of Research (MMG 250)
OR: Molecular Genetics (Mol Bio 207)
OR: Developmental Genetics (Dev Bio 210)
Summer Quarter: Qualifying examination.
Year 2:
Fall Quarter: University Teaching (Mol Bio 399); Research
in Experimental Pathology (Path 200A); Advanced Studies in Experimental
Pathology (Path 203A); Seminars in Experimental Pathology (Path 204).
Winter Quarter: University Teaching (Mol Bio 399); Path 200B, Path 203B,
Path 204.
Spring Quarter (odd years): Path 200C, Path 203C, Path 204, and Molecular
Mechanisms of Human Disease (Path 225/MMG 225).
Spring Quarter (even years): Path 200C, Path 203C, Path 204.
Year 3:
Fall Quarter: Path 200A, Path 203A, Path 204.
Winter Quarter: Path 200B, Path 203B, Path 204.
Spring Quarter (odd years): Path 200C, Path 203C, Path 204, and Molecular
Mechanisms of Human Disease (Path 225/MMG 225).
Spring Quarter (even years): Path 200C, Path 203C, Path 204.
Fall, Winter, or Spring Quarter: One elective course.
Summer Quarter: Advancement to Candidacy.
Year 4:
Fall Quarter: Path 200A, Path 203A, Path 204.
Winter Quarter: Path 200B, Path 203B, Path 204.
Spring Quarter: Path 200C, Path 203C, Path 204.
Fall, Winter, or Spring Quarter: One elective course.
Year 5:
Fall Quarter: Path 200A, Path 203A, Path 204.
Winter Quarter: Path 200B, Path 203B, Path 204.
Spring Quarter: Path 200C, Path 203C, Path 204.
Fall or Winter: One elective course.
Spring Quarter: Dissertation Defense.
8. Normative Time from Matriculation to Degree.
The normative time from matriculation to completion of the
Doctoral degree is five years (before the beginning of
the 16th academic quarter*). The first year is in the
MBGB program and the remaining four years in the Department
of Pathology & Laboratory Medicine doing thesis work in the laboratory of Experiment
Pathology faculty. Students may also perform thesis work in
the laboratories of affiliate faculty, currently including
faculty from the Departments of Molecular Biology and Biochemistry,
Physiology and Biophysics, Developmental & Cell Biology, and Biological Chemistry. As indicated above,
the normative time from matriculation to advancement to candidacy
(i.e., pre-candidacy) is three years (before the beginning
of the 10th academic quarter) and the normative time to the
Ph.D. in candidacy, two years. All students are required
to defend their theses by the end of their seventh year (before
the beginning of the 22nd academic quarter).
*The 10th academic quarter would be the beginning of the fourth
year, so normative time to advancement would be during the
third year of graduate school, including the summer of the
third year. Similarly the 16th and 22nd academic quarters would
be before the beginning of the 6th and 8th years.
III. COURSES
1. Courses Offered in Pathology & Laboratory Medicine.
Path 200A, 200B, 200C: Research in Experimental
Pathology - Taught by Pathology & Laboratory Medicine Faculty.
Path 203A, 203B, 203C: Advanced Studies in Experimental
Pathology - Taught by Pathology & Laboratory Medicine Faculty.
Path 204: Experimental
Pathology Research Seminar - Attendance and participation in
the departmental research seminar series.
Path 221: Immunopathogenic Mechanisms of Disease. Taught by A.J. Ouellette, Ph.D. Joint
listed as MMG 221. 3 units, Winter quarter in even numbered
years.
Path 225: Molecular Mechanisms of
Human Disease. Taught by W.E. Robinson, Jr., M.D, Ph.D. Joint
listed as MMG 225. 3 units, Spring quarter in odd numbered
years.
Path 230D: Principles of Experimental
Pathology - Taught by the faculty of the Department of Pathology & Laboratory Medicine.
4 units, Fall quarter.
Path 231A: Pathology of Cardiovascular
Diseases - Taught by the faculty of the Department of Pathology & Laboratory Medicine.
2 units, Fall quarter.
Path 232A: Pathology of Pulmonary
Diseases - Taught by the faculty of the Department of Pathology & Laboratory Medicine.
1.5 units, Fall quarter.
Path 233A: Pathology of Renal Diseases
- Taught by the faculty of the Department of Pathology & Laboratory Medicine. 1 unit,
Fall quarter.
Path 234A, 234B: Pathology of Gastrointestinal
Diseases - Taught by the faculty of the Department of Pathology & Laboratory Medicine.
2 units, Fall through Winter quarters.
Path 235A, 235B: Pathology of Genitourinary
Tract Diseases - Taught by the faculty of the Department of
Pathology & Laboratory Medicine. 2 units, Fall through Winter quarters.
Path 236B: Graduate Neuropathology
- Taught by the faculty of the Department of Pathology & Laboratory Medicine. 1.5
units, Winter quarter.
Path 271AB: Molecular Physiology & Disease - Taught by the faculty of the Department of Physiology and Biophysics. Joint listed as Pharm 271AB and Physio 271AB. 4 units, 271A is Fall of even numbered years and 271B is Fall of odd numbered years.
NB: Path 230-236 are sections of the
second year medical school pathology course, 508ABC. Graduate
students may take portions of the course for credit as indicated
by these courses. The students will, in addition to attending
the class sections, work in small groups with a faculty member
and will discuss experimental approaches to the medical problems
taught in the course. Each student will submit written hypotheses,
aims, and experimental approaches relevant to a pathologic
problem of current import. Student evaluations will be made based on attendance,
students participation in the discussions and the quality
of their written experimental plans.
2. Supporting Courses.
BC 212: Signal Transduction and Growth Control
DB 210: Developmental Genetics
DB 231B: Cell Biology
DB 231D: Cellular, Molecular, & Developmental Neurobiology
MBB 204: Structure and Functions of
Proteins
MBB 203: Structure and Biosynthesis of Nucleic Acids
MBB 206: Regulation of Gene Expression
MBB 207: Molecular Genetics
MBB 399: University Teaching
MMG 215: Molecular Immunology
MMG 221: Immunopathogenic Mechanisms of Disease
MMG 222-: Molecular Pathogenesis of Viral Infections
|